A recent editorial by S. Danti et al. highlights how 3D biomaterial-assisted in vitro models are transforming cancer research by offering a more accurate representation of tumor biology compared to traditional 2D cultures. These advanced models, supported by platforms like #MIVO, significantly improve the mimicry of in vivo cell interactions, tissue architecture, and therapeutic responses. The MIVO platform provides a highly biomimetic system that precisely models the #TumorMicroenvironment, leading to enhanced predictivity in drug sensitivity and treatment outcomes. It allows researchers to explore complex biological processes—such as cellular responses to therapies—far beyond the capabilities of conventional 2D models.
Chi siamo
React4Life is an Italian biotech company transforming the preclinical research landscape by successfully addressing challenges for hundreds of clients worldwide. At the heart of React4Life lies our revolutionary MIVO® technology, backed by over two decades of dedicated academic research. We are pioneers in the development of MIVO®-based organ-on-chip systems, representing a breakthrough in microphysiological technology for faithfully recapitulating human biology in the lab. MIVO® human on chip platform overcomes the limits of traditional in vitro assays and animal models. It improves the reliability and predictivity of several applications in the fields of drug testing, personalized medicine, immuno-oncology, dermocosmetics, and nutraceuticals. At React4life, Italian creativity transforms biotech challenges into customized, cutting-edge solutions. Our worldwide clients' feedback fuels our commitment to meeting their evolving needs. Learn more at www.react4life.com
- Sito Web
-
https://www.react4life.com
Link esterno per React4life
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 2-10 dipendenti
- Sede principale
- Genova, Liguria
- Tipo
- Società privata non quotata
- Data di fondazione
- 2016
- Settori di competenza
- R&D, Biotechnology, Life Science, Bioreactors, Cell culture, Toxicity tests, Digestibility tests, In vitro tests, Permeability tests, organ-on-chip e microphysiological systems
Località
-
Principale
Via Greto di Cornigliano, 6r
Genova, Liguria 16152, IT
Dipendenti presso React4life
-
Maurizio Aiello
CEO React4life S.p.A., Senior Technologist CNR, MBA candidate
-
Luca A. Baroldi Torelli, M.D.
Board Member X TE! Innovative Healthcare Services. Shareholder & Mentor presso React4life. Shareholder Hemera Pharma.
-
Natalia Ozimo
LifeScience | Biotech | Organ-on-chip
-
Silvia Scaglione
Chief Research Officer React4life, CNR researcher, Gamma Donna Ambassador
Aggiornamenti
-
By closely replicating physiological conditions, our MIVO-based Gut on Chip allows for precise pre-screening of compounds, assessment of active ingredient permeation, and investigation of mechanisms of action. This human-relevant model supports bioavailability and efficacy testing while offering valuable insights into pharmacokinetics and pharmacodynamics, which are critical for successful drug development.
-
🚀 We're on Stage with our CEO, Maurizio Aiello at the 2024 BioTools Innovator Capstone Event! 🚀 #biotools #bticapstone24 #lifesciencetools #biotech #pharma
-
🌟 Exciting times ahead at BioProcess International, part of #BWB Biotech Week Boston! 🚀 We’re thrilled to connect with scientists, technologists, and key players across the biopharmaceutical landscape at this flagship event. We're ready to explore new ideas, forge partnerships, and uncover exciting opportunities in the industry!
-
🌟 Our Ph.D. student, Gergő Borka, participated in the Annual Meeting organized by the TeCSBi PhD Course Università degli Studi di Milano-Bicocca, where he showcased the main results and progress of his research project. Bravo Greg! Keep up the great work! 👏
PhD student at React4Life, Student at the University of Milano-Bicocca,Recipient of the Marie Skłodowska-Curie Grant -the GlycoNoVi Project
What an exciting time at the Università degli Studi di Milano-Bicocca! 🔬 🇮🇹 The 16th TeCSBI PhD meeting has concluded on the 18th of September - full of remarkable presentations and lectures! I am grateful I could participate and represent our company React4life!
-
🎉 Exciting News! 🎉 We are thrilled to announce that after winning the #CPHI Pharma Award 2023 in the Accelerating Innovation category, React4life is once again a finalist in the same category, this time with our unique Gut-Skin model! This nomination highlights the relentless innovation and hard work of our team. The winners will be revealed at the CPHI Pharma Award Celebration on October 8th in Milan. We couldn’t be prouder! Come and join us in celebrating this exciting achievement! 🎉 For more details, visit: https://lnkd.in/eTB4R5sD
-
🙌 Keep voting us!!! 🙌
React4life develops clinically relevant organ on chip platforms for mirroring human complexity in vitro. Watch their pitch video & like it on YouTube to vote for them to win the $10K #BTIBestVideo https://lnkd.in/g5gaFgwh Join React4life at the Capstone event in Boston on 9/26: https://hubs.ly/Q02NC6ns0. Maurizio Aiello
React4life: 2024 BTI Best Video Competition
https://www.youtube.com/
-
🎉 Dear partners and friends, We need your support to make an even greater impact at the BioTools Innovator CapStone event on September 26th in Boston! 🎬 Please watch, like, and share our 1-minute video for the 2024 Best Video Competition 👉 https://lnkd.in/g5gaFgwh Help us spread the word by sharing it with your network – every view and like makes a difference!
We're officially launching the BioTools Innovator Best Video Competition! This week, we will feature the 1-min pitch videos from the talented BTI '24 cohort. Be part of the action and vote for your favorites by watching, liking and sharing their 1-min videos. The finalists will compete for the $10k at the Capstone Event on September 26 in Boston at the BioProcess International Conference. Register for and vote live at the event here: https://hubs.ly/Q02NC6ns0 Check out our 2023 Best Video Winner ReelReactor -> https://lnkd.in/gyH9Z-ik #bestvideocompetition #biotech #biotools #lifesciences
-
In his recent interview with il Bollettino, our CEO, Maurizio Aiello, delved into the rapid growth of the organ-on-chip market. With regulatory bodies like the EMA and FDA advocating for alternatives to animal testing, these advanced technologies are gaining significant traction. At React4life, we are driving innovation with a clear growth strategy—focused on strengthening our R&D efforts through new product development and validation processes to accelerate expansion. The potential for organ-on-chip technology is immense, and we’re proud to be at the forefront of this exciting revolution! 🚀 Check out the full interview with Maurizio here 👇 https://lnkd.in/dJjuxHAS
💸 I finanziamenti globali per la #sanità digitale si sono dimezzati per il secondo anno consecutivo nel 2023, mentre gli accordi sono diminuiti di oltre un terzo. Il peggio, però, potrebbe già essere passato. 💊 Nonostante i cali, la dimensione media delle #transazioni è rimasta pari a 4 milioni di dollari, la più alta mai registrata. Un segnale positivo, che rema controcorrente. 🔬 «Il Mercato dell’organ-on-chip è agli albori, ma in forte espansione. Questo perché gli enti regolatori (EMA, FDA) stanno spingendo verso lo sviluppo e l’adozione di #tecnologie alternative alla sperimentazione animale. Il nostro modello di business è.…», continua a leggere l’intervista a Maurizio Aiello, Co-Founder & CEO di React4life ✍️ Marta Colazzo #startup #health #care #mercato https://lnkd.in/dJjuxHAS
-
🚀 New Must-See Webinar! 🚀 Join us on Sep 18th to gain deeper insights into how our gut-on-chip model enhances predictivity in human intestinal research! Our Senior Scientist, Elisabetta Palamà, will guide us through the complex and dynamic #gut ecosystem and explain how our innovative approach offers precise control over mucus thickness and barrier integrity—key factors in studying intestinal diseases, drug absorption, and host-microbiota interactions. Don’t miss this opportunity to explore cutting-edge research! Register now! 👉 https://lnkd.in/dGetHZW4
Questo contenuto non è disponibile qui
Accedi a questo contenuto e molto altro nell’app LinkedIn
Pagine simili
Sfoglia le offerte di lavoro
Raccolta fondi
Ultimo round
Finanziamento del debito